{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T22:16:27Z","timestamp":1785017787306,"version":"3.55.0"},"reference-count":50,"publisher":"The Journal of Rheumatology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Multimorbidity, the coexistence of 2 or more conditions in an individual, is associated with morbidity and mortality in the general population. This study aims to describe the prevalence of multimorbidity in axial spondyloarthropathy (axSpA) and assess its association with disease outcome measures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>This cross-sectional study was conducted within the Ankylosing Spondylitis Registry of Ireland (ASRI) cohort. Structured standardized assessment was performed. Multimorbidity was considered as the presence of at least 1 physician-diagnosed chronic condition (excluding extraarticular manifestations) in addition to axSpA. Validated outcome measures were collected: Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath AS Functional Index (BASFI), Health Assessment Questionnaire (HAQ), AS Quality of Life (ASQoL), and Bath AS Metrology Index (BASMI). Adjusted multiple regression was performed to investigate the association between multimorbidity and disease outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>A total of 734 patients from 12 centers were included: 77% male, mean (SD) age 45 (12) years. Of the cohort, 55% (n = 403) were multimorbid. Multimorbid patients were significantly (p &lt; 0.01) older than axSpA-only patients [50 (12) vs 40 (11) yrs]. Obesity was the most prevalent chronic condition, affecting 27%. Multimorbid patients had more severe disease than patients with axSpA only. After adjusting for confounders, multimorbidity was associated with higher BASDAI (\u00df 0.7, 95% CI 0.34\u20131.05), BASMI (\u00df 0.45, 95% CI 0.09\u20130.80), BASFI (\u00df 0.5, 95% CI 0.23\u20130.78), HAQ (\u00df 0.07, 95% CI 0.00\u20130.13), and ASQoL (\u00df 0.87, 95% CI 0.28\u20131.46).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Multimorbidity is prevalent in axSpA and is associated with more severe disease.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.181415","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T12:36:41Z","timestamp":1557923801000},"page":"218-226","source":"Crossref","is-referenced-by-count":25,"title":["Multimorbidity in Axial Spondyloarthropathy and Its Association with Disease Outcomes: Results from the Ankylosing Spondylitis Registry of Ireland Cohort"],"prefix":"10.3899","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5930-3928","authenticated-orcid":false,"given":"Gillian","family":"Fitzgerald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9465-650X","authenticated-orcid":false,"given":"Finbar D.","family":"O\u2019Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2019,5,15]]},"reference":[{"key":"2020020109251873000_47.2.218.1","unstructured":"European Commission . The 2015 Ageing Report: economic and budgetary projections for the 28 EU member states (2013\u20132060). [Internet. Accessed August 21, 2019.] Available from: ec.europa.eu\/economy_finance\/publications\/european_economy\/2015\/pdf\/ee3_en.pdf"},{"key":"2020020109251873000_47.2.218.2","first-page":"1","article-title":"United States life tables, 2013","volume":"66","author":"Arias","year":"2017","journal-title":"Natl Vital Stat Rep"},{"key":"2020020109251873000_47.2.218.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)62087-X"},{"key":"2020020109251873000_47.2.218.4","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(09)61460-4"},{"key":"2020020109251873000_47.2.218.5","doi-asserted-by":"publisher","DOI":"10.2307\/3349864"},{"key":"2020020109251873000_47.2.218.6","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-1733-2"},{"key":"2020020109251873000_47.2.218.7","unstructured":"World Health Organization . Global status report on noncommunicable diseases 2014. [Internet. Accessed August 21, 2019.] Available from: www.who.int\/nmh\/publications\/ncd-status-report-2014\/en"},{"key":"2020020109251873000_47.2.218.8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.15256\/joc.2016.6.72","article-title":"Multimorbidity: what do we know? What should we do?","volume":"6","author":"Navickas","year":"2016","journal-title":"J Comorb"},{"key":"2020020109251873000_47.2.218.9","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.212"},{"key":"2020020109251873000_47.2.218.10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.15256\/joc.2013.3.22","article-title":"The coexistence of terms to describe the presence of multiple concurrent diseases","volume":"3","author":"Almirall","year":"2013","journal-title":"J Comorb"},{"key":"2020020109251873000_47.2.218.11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102149"},{"key":"2020020109251873000_47.2.218.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60240-2"},{"key":"2020020109251873000_47.2.218.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(00)00368-1"},{"key":"2020020109251873000_47.2.218.14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002571"},{"key":"2020020109251873000_47.2.218.15","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp18X695465"},{"key":"2020020109251873000_47.2.218.16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/acr.22996","article-title":"Patterns and consequences of multimorbidity in the general population: there is no chronic disease management without rheumatic disease management","volume":"69","author":"Simoes","year":"2017","journal-title":"Arthritis Care Res"},{"key":"2020020109251873000_47.2.218.17","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/acr.22913","article-title":"Impact of chronic diseases and multimorbidity on health and health care costs: the additional role of musculoskeletal disorders","volume":"68","author":"van der Zee-Neuen","year":"2016","journal-title":"Arthritis Care Res"},{"key":"2020020109251873000_47.2.218.18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.berh.2017.09.004","article-title":"The contribution of musculoskeletal disorders in multimorbidity: implications for practice and policy","volume":"31","author":"Duffield","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2020020109251873000_47.2.218.19","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.141534"},{"key":"2020020109251873000_47.2.218.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.06.010"},{"key":"2020020109251873000_47.2.218.21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev239"},{"key":"2020020109251873000_47.2.218.22","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s10067-018-4086-2","article-title":"Evaluation of the comorbidity burden in patients with ankylosing spondylitis using a large US administrative claims data set","volume":"37","author":"Walsh","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2020020109251873000_47.2.218.23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208174"},{"key":"2020020109251873000_47.2.218.24","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/acr.23468","article-title":"Association of comorbidities in spondyloarthritis with poor function, work disability, and quality of life: results from the Assessment of SpondyloArthritis International Society Comorbidities in Spondyloarthritis study","volume":"70","author":"Nikiphorou","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2020020109251873000_47.2.218.25","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2470"},{"key":"2020020109251873000_47.2.218.26","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207688"},{"key":"2020020109251873000_47.2.218.27","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.151191"},{"key":"2020020109251873000_47.2.218.28","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1007\/s10067-016-3362-2","article-title":"Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study","volume":"35","author":"Ahmed","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2020020109251873000_47.2.218.29","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20408"},{"key":"2020020109251873000_47.2.218.30","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210770"},{"key":"2020020109251873000_47.2.218.31","unstructured":"Health Service Executive . About the alcohol programme \u2013 healthy Ireland. [Internet. Accessed August 21, 2019.] Available from: www.hse.ie\/eng\/health\/hl\/change\/alcohol"},{"key":"2020020109251873000_47.2.218.32","first-page":"1694","article-title":"Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index","volume":"21","author":"Jenkinson","year":"1994","journal-title":"J Rheumatol"},{"key":"2020020109251873000_47.2.218.33","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90218-E"},{"key":"2020020109251873000_47.2.218.34","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"2020020109251873000_47.2.218.35","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"Calin","year":"1994","journal-title":"J Rheumatol"},{"key":"2020020109251873000_47.2.218.36","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780230202"},{"key":"2020020109251873000_47.2.218.37","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.1.20"},{"key":"2020020109251873000_47.2.218.38","doi-asserted-by":"publisher","DOI":"10.3109\/13814789609162146"},{"key":"2020020109251873000_47.2.218.39","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2468-2667(18)30091-4","article-title":"Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants","volume":"3","author":"Hanlon","year":"2018","journal-title":"Lancet Public Health"},{"key":"2020020109251873000_47.2.218.40","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s13104-016-2121-4","article-title":"Prevalence of self-reported multimorbidity in the general population and in primary care practices: a cross-sectional study","volume":"9","author":"Mokraoui","year":"2016","journal-title":"BMC Res Notes"},{"key":"2020020109251873000_47.2.218.41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-1161"},{"key":"2020020109251873000_47.2.218.42","doi-asserted-by":"crossref","first-page":"e9930","DOI":"10.1097\/MD.0000000000009930","article-title":"Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity: single center real life results","volume":"97","author":"Armagan","year":"2018","journal-title":"Medicine"},{"key":"2020020109251873000_47.2.218.43","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glq208"},{"key":"2020020109251873000_47.2.218.44","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ecl.2016.04.004","article-title":"Regarding obesity as a disease: evolving policies and their implications","volume":"45","author":"Kyle","year":"2016","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020020109251873000_47.2.218.45","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.113905"},{"key":"2020020109251873000_47.2.218.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.01.004"},{"key":"2020020109251873000_47.2.218.47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jbspin.2018.06.010","article-title":"Impact of comorbidities on fatigue in rheumatoid arthritis patients: results from a nurse-led program for comorbidities management (COMEDRA)","volume":"86","author":"Tournadre","year":"2019","journal-title":"Joint Bone Spine"},{"key":"2020020109251873000_47.2.218.48","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)61412-X"},{"key":"2020020109251873000_47.2.218.49","doi-asserted-by":"crossref","first-page":"965956","DOI":"10.1155\/2012\/965956","article-title":"Prevalence and characteristics of lung involvement on high resolution computed tomography in patients with ankylosing spondylitis: a systematic review","volume":"2012","author":"El Maghraoui","year":"2012","journal-title":"Pulm Med"},{"key":"2020020109251873000_47.2.218.50","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00296-011-1923-x","article-title":"Pulmonary abnormalities on high-resolution computed tomography in ankylosing spondylitis: relationship to disease duration and pulmonary function testing","volume":"32","author":"Ozdemir","year":"2012","journal-title":"Rheumatol Int"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.181415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T12:26:43Z","timestamp":1580560003000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.181415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,15]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,1]]},"published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.3899\/jrheum.181415"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.181415","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,15]]}}}